| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dmx like 1 | 0.805 | 0.154 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
MYB proto-oncogene like 1 | 0.705 | 0.308 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ATPase Na+/K+ transporting subunit beta 2 | 0.705 | 0.308 | 7.4E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
pleckstrin homology like domain family B member 1 | 0.722 | 0.423 | 0.11 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
pleckstrin and Sec7 domain containing 3 | 0.691 | 0.423 | 9.5E-03 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
high mobility group nucleosome binding domain 5 | 0.650 | 0.423 | 0.31 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
H3 clustered histone 2 | 0.653 | 0.423 | 1.5E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
family with sequence similarity 107 member A | 0.674 | 0.462 | 8.3E-07 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
chloride voltage-gated channel 2 | 0.626 | 0.462 | 5.5E-12 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
QKI, KH domain containing RNA binding | 0.617 | 0.500 | 0.75 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
chloride voltage-gated channel 5 | 0.593 | 0.577 | 0.99 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
SUZ12 polycomb repressive complex 2 subunit | 0.529 | 0.577 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
apolipoprotein D | 0.584 | 0.577 | 5.4E-04 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
chloride voltage-gated channel 3 | 0.621 | 0.615 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
CCDC26 long non-coding RNA | 0.647 | 0.615 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
tripartite motif containing 29 | 0.606 | 0.654 | 8.1E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
H3.3 histone A | 0.559 | 0.692 | 0.12 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
MYB proto-oncogene, transcription factor | 0.490 | 0.692 | 0.82 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2013 | 2016 | ||||||||
|
neurotrophic receptor tyrosine kinase 3 | 0.522 | 0.692 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
activin A receptor type 1 | 0.535 | 0.731 | 0.33 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2014 | 2014 | ||||||||
|
C-C motif chemokine receptor 4 | 0.510 | 0.731 | 6.9E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ferritin heavy chain 1 | 0.559 | 0.731 | 0.14 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
DNA topoisomerase II alpha | 0.497 | 0.731 | 0.99 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
protection of telomeres 1 | 0.560 | 0.731 | 0.85 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2009 | 2009 |